BioSpace News Archive

exocad GmbH, an Align Technology, Inc. company, announced the availability of exoplan 3.0 Galway, the latest version of its implant planning software.

The easy-to-use, lab-free Covid-19 (SARS-CoV-2) antigen test solution aims to provide reliable results in around 15 minutes at the point-of-care The objective is affordable, rapid mass testing by analyzing saliva samples and allowing digital results to be uploaded to a medical cloud Innovative approach using ams spectral sensors to enable test results which are easy to read and conclusive Initial results, on inactivated virus particles,

Quantzig, a premier data analytics and advisory firm, announces the launch of its comprehensive portfolio of analytics solutions for the pharma and life sciences industry . Effective management of the vital information available to pharma and life sciences companies plays a crucial role in achieving breakthroughs in drug development and patient care. Hence, just like the healthcare industry, the pharma and life sciences

Q BioMed, Inc. (OTCQB: QBIO) is pleased to announce that its technology partner Mannin Research Inc. (MRI), a private Canadian biotechnology company, is a member of the Canadian national COVID Cloud consortium. The platform will be used by MRI to

Patents and patent application provide additional coverage for company’s therapeutic for patients with advanced solid tumors

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that it has been selected for inclusion in the NASDAQ Biotechnology Index (Nasdaq: NBI), based on the results of the annual reconstitution of the index announced by Nasdaq on December

Battelle’s innovative design teams will focus on expanding the capabilities of Aprecia’s 3DP technology platform addressing important pharmaceutical product challenges through 3DP innovation

MYOS CORP (“MYOS” or the “Company”), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health , announced today that it has entered into an agreement with Science Biotech to exclusively distribute its Fortetropin ® products in Australia and New Zealand. Fortetro

Phoenix PharmaLabs, a privately held, preclinical drug company dedicated to developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced it has launched its second offering campaign on the Netcapital platform: https://netcapital.com/companies/phoenix .